Genetic variants associated with Lp(a) lipoprotein level and coronary disease. - Wikidata - wikimedia - TriplyDB

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.

http://www.wikidata.org/entity/Q50572117

about

Variation in LPA is associated with Lp(a) levels in three populations from the Third National Health and Nutrition Examination Survey Personalized medicine: hope or hype?Apolipoprotein(a) acts as a chemorepellent to human vascular smooth muscle cells via integrin αVβ3 and RhoA/ROCK-mediated mechanisms Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)Clinical assessment incorporating a personal genome Lipoprotein(a) as a cardiovascular risk factor: current status The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010?Oxidized phospholipids and lipoprotein-associated phospholipase A2 as important determinants of Lp(a) functionality and pathophysiological role Lipoprotein apheresis for the treatment of elevated circulating levels of lipoprotein(a): a critical literature review Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics Familial hypercholesterolemia: an under-recognized but significant concern in cardiology practice Current therapies for lowering lipoprotein (a)New therapeutic principles in dyslipidaemia: focus on LDL and Lp(a) lowering drugs Genetics of lipid traits and relationship to coronary artery disease Genome-wide association studies of late-onset cardiovascular disease Genetics of the acute coronary syndrome Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future Mendelian Randomization and Type 2 Diabetes New Era of Lipid-Lowering Drugs Impact of L-carnitine on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled trials Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases The Genetic Basis of Coronary Artery Disease and Atrial Fibrillation: A Search for Disease Mechanisms and Therapeutic Targets Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia Lipoprotein(a) and risk of myocardial infarction--genetic epidemiologic evidence of causality Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitine Large-scale gene-centric analysis identifies novel variants for coronary artery disease Genetic variation in the human brain dopamine system influences motor learning and its modulation by L-Dopa Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF Population genomics of cardiometabolic traits: design of the University College London-London School of Hygiene and Tropical Medicine-Edinburgh-Bristol (UCLEB) Consortium Association between the interleukin-6 promoter polymorphism -174G/C and serum lipoprotein(a) concentrations in humans Large-scale candidate gene analysis of HDL particle features Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk Reduction Mendelian randomization in cardiometabolic disease: challenges in evaluating causality.The Role of Emerging Risk Factors in Cardiovascular Outcomes Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis.

P2860

Q21135561-C4ABC00E-09D7-4EB5-B0AA-82C869710ED7 Q24289193-5E94A578-EF58-40D3-847E-59246BC78A12 Q24294266-82681382-C911-4434-88BF-059A98D30EFE Q24594382-F84E9A95-E148-4D32-8F1C-908C1CCE201E Q24612653-318BF4C4-CB20-4117-BD72-89EFB102AB6B Q24623225-63640313-CC5F-4267-BBBF-3A1C794BD89C Q24632581-CF012A79-F726-4569-9D43-9DC77E3C8DE1 Q26747100-B54BCD33-3612-4ED4-8513-00EBC7E00561 Q26771862-FAF1CBCD-6B68-4A0E-8491-A0D44E39E251 Q26822796-BCA1885C-AC9C-4373-9428-61DA0D7A2EB7 Q26828401-A94B4807-8C2A-4441-AFF5-9CF61E4C58D4 Q26830297-B014F99D-5090-4F88-AD63-89A697E6D6FE Q26863369-28347CB3-9F70-400A-8834-9D9DCBFD432E Q26995252-DAADD985-BF74-4926-95A7-E72B1A5440BA Q27012711-D9D83117-6CFF-4CD8-9FF3-0235CC471C96 Q28066981-9E337F7C-42AC-4EA4-9953-0F993A51A8C2 Q28070061-C69483A9-7A8F-48C2-AC8B-79B686C184A7 Q28072229-1C9B4E92-FE3A-42EC-AFDE-51055B78F623 Q28072298-543C4321-4C78-40E1-A28A-93D4ADAF99D5 Q28077742-AEF42D2E-C043-4FB6-B416-12275712BB1A Q28079294-2C1E899C-FEF5-4C95-BAC3-87F89B947B3C Q28080690-FD7B6391-F58A-43F2-8E1E-09D2016B9642 Q28254321-50E6C45F-26D7-47D0-90B5-B77DA723FBDA Q28267020-3859110A-509D-4F0A-AB6D-972C6109FD39 Q28275648-D52E6CD6-7AB6-47B0-8F9B-81E50EFD0D5D Q28303150-FBDC6E1B-BDAF-4C8F-BC77-FA8FF806D88F Q28395286-E82901AE-4345-4C1A-B967-65D7096DDEA8 Q28477187-42FAEF58-CB1F-47A0-B54F-D20CF1CBE429 Q28486256-8ED8150D-92A6-444E-AAAB-C5A056938A29 Q28607764-665EBA03-575F-4383-B048-C34893013CB7 Q28681745-577D334D-B461-41A0-86A6-19D25D5DB34C Q28740387-4333E953-786B-4D10-A96F-998FD7587B4F Q28743354-28576110-C7DD-42D4-9166-31E302C0B1EB Q29417023-151DDEA2-3807-4E61-98C5-BE0C93CA4E4C Q29999973-3CA9EA76-2A2E-4341-AA6C-7847EE0382D7 Q30234302-98A36DC9-03D4-4B69-B97F-174342F04743 Q30234550-A15F70B3-8BE2-4987-996F-F8A3BE33BBFB Q30234679-6F93D625-0035-4D04-8EF7-128BE6907808 Q30242031-96CBDD11-B918-47EC-8BFA-15349BF4D9EB Q30411394-A19653C5-3A39-4C0C-AE2D-BF0F91F9E610

P2860

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.

http://www.wikidata.org/entity/Q50572117

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Genetic variants associated with Lp

@nl

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.

@en

type

label

Genetic variants associated with Lp

@nl

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.

@en

prefLabel

Genetic variants associated with Lp

@nl

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.

@en

P1433

Q50572117-6897D1EB-DCB4-49AF-8A6F-D770C94F68A9

P1476

Q50572117-E39F3574-988A-4AFC-A7FE-A96FC402D247

P2093

Q50572117-16288AB9-30B9-4086-8698-6152B9D12658

Q50572117-2111B259-79A8-437F-A3D4-B66923818A68

Q50572117-298FEF13-2DDF-4F7F-A7FE-1C23792B1B28

Q50572117-3213011B-058C-48EA-BDF1-6A7F115E7BEF

Q50572117-32369937-3BF9-4CF5-A6E4-EFBFCBEA5AD9

Q50572117-5CA908A3-D566-42EF-9C14-3A1372AD16F2

Q50572117-619B6E40-8D51-43E6-B9CD-A34D1CD6C5D2

Q50572117-70523046-B26D-4C73-B543-9BF5D01A4FA7

Q50572117-813CEEDF-64E3-4200-B510-82723A695F95

Q50572117-95839B50-FF27-4AE4-9D64-A9C7EACA66C6

P304

Q50572117-D4D2B6F4-BB3B-4395-AEB0-EECD4A8DCE72

P31

Q50572117-6F488906-4CB5-4A87-96E1-FE6A5A145EA7

P356

Q50572117-6F6B1D4C-0F86-4B8C-A3FA-87929E472F8D

P407

Q50572117-03D536FE-EBF1-474F-9CB3-316098DC36FC

P433

Q50572117-0C911AAF-81FA-43C6-A08A-0097B0DE4F1E

P478

Q50572117-0863B18C-C483-44E4-BB75-F66514309EEC

P50

Q50572117-167BA350-0B1A-4872-8D4A-EA1E45DE4E53

Q50572117-2983B568-D754-4E9B-966B-32DE67CD68A2

Q50572117-468723D4-0665-4405-A514-608ADEB96617

Q50572117-507159FB-99BE-4080-84DE-9ED56A43D930

Q50572117-637FCE6E-2F30-4E89-B3E2-B4CF96C3B57A

Q50572117-66B9D397-4B26-4260-A4D3-F84BC63AA833

Q50572117-D51DD33C-242E-4102-94D0-5B152A77B5C3

Q50572117-D6C3F5A7-5395-43AF-9796-230862E4D4DC

Q50572117-DCAED247-19C6-4465-B0B6-D26C3CEA4BB9

P577

Q50572117-9C2016E7-AF0B-4311-ACA5-2863E1F96AB4

P698

Q50572117-D944DA1F-8840-4449-A8A9-3049AAF99F60

P921

Q50572117-F6113443-CE47-4B25-BE60-AB0B154CEBA7

P356

P1433

The New England Journal of Medicine

P1476

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.

@en

P2093

Angela Silveira

http://www.w3.org/2001/XMLSchema#string

Anuj Goel

http://www.w3.org/2001/XMLSchema#string

Bruna Gigante

http://www.w3.org/2001/XMLSchema#string

Derrick Bennett

http://www.w3.org/2001/XMLSchema#string

Fiona R Green

http://www.w3.org/2001/XMLSchema#string

Jemma C Hopewell

http://www.w3.org/2001/XMLSchema#string

John F Peden

http://www.w3.org/2001/XMLSchema#string

Maria Grazia Franzosi

http://www.w3.org/2001/XMLSchema#string

Martin Farrall

http://www.w3.org/2001/XMLSchema#string

PROCARDIS Consortium

http://www.w3.org/2001/XMLSchema#string

P304

2518-2528

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA0902604

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

361

http://www.w3.org/2001/XMLSchema#string

P50

Anders Mälarstig

Theodosios Kyriakou

Hugh Christian Watkins

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20032323

http://www.w3.org/2001/XMLSchema#string

P921